BEVACIZUMAB
Clinical trials for BEVACIZUMAB explained in plain language.
Never miss a new study
Get alerted when new BEVACIZUMAB trials appear
Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cancer drug tame HHT's dangerous heart and liver complications?
Disease control ENROLLING_BY_INVITATIONThis study looks at how well and how safely the drug bevacizumab works for people with hereditary hemorrhagic telangiectasia (HHT) who have severe liver issues causing high heart output and possible heart failure. Researchers will check heart function before and after 6 months of…
Matched conditions: BEVACIZUMAB
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 26, 2026 09:20 UTC
-
New drug cocktail targets Hard-to-Treat colorectal cancer
Disease control TerminatedThis study tests whether a combination of four drugs (BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab) can help control advanced colorectal cancer that has stopped responding to standard treatments. The trial includes 7 adults with a specific type of cancer called …
Matched conditions: BEVACIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC